Camlin Fine Sciences Ltd Stock Analysis

BSE: 532834 | NSE: CAMLINFINE | Chemicals | Small Cap

BSE Share Price Jan 21, 18:01
153.10 -5.40 (-3.41%)

DeciZen - Make an Informed Decision on Camlin Fine Sciences

Overall Rating

1. Quality

2. Valuation

Fair
P/E P/S EV/EBITDA

3. Price Trend

FAQ's

1. Is Camlin Fine Sciences Ltd a good quality company?

Data is not available for this company.

2. Is Camlin Fine Sciences Ltd undervalued or overvalued?

The key valuation ratios of Camlin Fine Sciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Camlin Fine Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Camlin Fine Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Camlin Fine Sciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 17%18.1%19.2%18.8%16.8%5.7%0.5%4.1%6.1%5.4%-
Value Creation Index 0.20.30.40.30.2-0.6-1.0-0.7-0.6-0.6-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 252314374431412325403548580600616
YoY Gr. Rt. %-24.4%19.4%15%-4.3%-21.2%24.1%36.1%5.8%3.5%-
Adj EPS 11.62.22.82.90.2-1.30.71.71.20.3
YoY Gr. Rt. %-58.3%33.1%28.1%3.2%-93.7%-833.3%NA130.6%-30.7%-
BVPS (₹) 5.36.58.110.212.516.825.526.83132.439.7
Adj Net Profit 9.615.320.526.627.71.9-16.18.820.214.73
Cash Flow from Ops. 7.913.112.926.450.9-30.1-5.2-44.673.926-
Debt/CF from Ops. 11.18.210.25.13.1-8.1-41.7-74.514.3-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 10.1%7.8%14.2%3.5%
Adj EPS 1.2%-16.7%NA-30.7%
BVPS 22.4218.34.4
Share Price 29.3% 6.8% 43.7% 42.5%

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % 21.227.729.930.525.41.3-6.32.65.63.50.7
Op. Profit Mgn % 14.414.515.714.516.58.51.1610.412.410.3
Net Profit Mgn % 3.84.95.56.26.70.6-41.63.52.50.5
Debt to Equity 1.81.81.71.41.31.40.710.90.90.4
Working Cap Days 180195197200232322338305315338403
Cash Conv. Cycle 5062596896181180152162168147

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 14.20%

Debt to equity has declined versus last 3 years average to 0.90

Sales growth is good in last 4 quarters at 10.49%

Return on Equity has declined versus last 3 years average to 0.70%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Camlin Fine Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0.3 3.6
TTM Sales (₹ Cr.) 616 1,267
BVPS (₹.) 39.7 47.1
Reserves (₹ Cr.) 494 588
P/BV 3.86 3.30
PE 604.39 42.67
From the Market
52 Week Low / High (₹) 100.60 / 230.80
All Time Low / High (₹) 1.94 / 230.80
Market Cap (₹ Cr.) 1,954
Equity (₹ Cr.) 12.8
Face Value (₹) 1
Industry PE 44.2

Management X-Ray of Camlin Fine Sciences :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *10.9510.8810.8810.880.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Camlin Fine Sciences Ltd

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956. In 2011
Company changed its name from Camlin Fine Chemicals Ltd. to Camlin Fine Sciences Ltd. 

Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants TBHQ and BHA. Its mission is to be the largest food antioxidant and ingredient manufacturer worldwide. Their facilities are HACCP and ISO 9001 : 2000 certified.

Product Range:

a) Food Ingredients –

Antox TBHQ (HACCP Certified) FCC V / FAO / WHO (Tertiary Butyl Hydroquinone)

Antox BHA (HACCP Certified) FCC V / FAO / WHO / EEC ( Butyl Hydroxy Anisole)

b) Sweetener -

Sucralose FCC V

c) Active Pharmaceutical Ingredients -

  • Miconazole Nitrate B.P. / USP
  • Clotrimazole B.P. / USP
  • Amlodipine Besilate E.P
  • Amlodipine Salts
  • Advance intermediate of Amlodipine
  • Intermediate of Miconazole Nitrate

d) Super Absorbent Polymer

Subsidiary Details:

  • Chemolutions Chemicals: Specialty Chemical Intermediates
  • Sangam Laboratories: Nutraceuticals
  • Fine Renewable Energy.
  • Fine LifeStyle Brands: Luxury Fashion Brands

On 6th June 2008 - The company entered into a joint venture, on 51:49 basis, with US based Viachem LLC, to set up a joint venture company under the name Dulcette Technologies for marketing Sucralose, Aspartame, and Acesulfame-K, and their belnds in USA, Canada, and Maxico.

On 7th July 2008 - The Board of Directors of the company at its meeting held on 29th July 2008, approved the proposal for setting up a joint venture company with Pagoda Advisors and their associates.

As per the deal, Camlin Fine Chemicals will get 51% of the equity of the proposed new company and the rest 49% will be owned by Pagoda Advisors and their associates.The proposed new company will focus on the retail of luxury/premium brands in India by setting up stores in all stores in all major metros and cities in India by itself and through franchisees.

On 25th February 2008:  Camlin Fine Chemicals acquired 60% equity stake in Sangam Laboratories, a Small Scale Unit manufacturing Nutraceuticals and Drug Intermediates at Tarapur.

On 12th February 2008 - The company inked a joint venture deal with US based Advanced Aerospace Technologies to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets.

Read More Read Less